IntelliAM AI Regulatory News (INT.PL)

2 May 2025

IntelliAM AI Plc

('IntelliAM' or the 'Company')

Board Appointment

IntelliAM AI plc (AQSE: INT), the software company leveraging the power of AI and machine learning in the manufacturing industry, announces the appointment of Dr Keith Harris to the board as non-executive director and Chairman-elect. Dr Harris will become Non-Executive Chairman on 1 July 2025.

Dr Harris is a highly regarded investment banker and corporate strategist with over 35 years of experience advising on complex cross-border M&A, equity and debt capital markets transactions, and corporate leadership. He has held senior roles at Morgan Grenfell, Drexel Burnham, and served as Chief Executive of HSBC Investment Bank. Dr Harris was also the principal owner and Chairman of Seymour Pierce Holdings and has held a number of high-profile board positions, including Chairman of Wembley National Stadium, and the Football League.

He currently serves as Chairman of NASDAQ-listed gene therapy company MeiraGTx and Executive Chairman of Global Connectivity Plc, quoted on AQSE.

Strategic Appointment to Support Next Growth Phase

This appointment comes at a time of increasing momentum for IntelliAM, as the Company scales its AI-powered solutions across global industrial sectors. Dr Harris's deep expertise in capital markets will be instrumental as IntelliAM accelerates its growth and explores strategic opportunities in the UK and internationally.

Tom Clayton, CEO of IntelliAM, commented:

"We are delighted to welcome Keith to the board. His extraordinary track record in capital markets and board leadership will bring enormous value to IntelliAM as we deepen our relationships with institutional investors and pursue our strategic growth initiatives."

Dr Harris, Chairman-elect, said:

"IntelliAM is delivering real transformation in a vital sector through the intelligent application of AI. I look forward to working with Tom and the board to support the company's ambitions and help realise its significant market potential."

Trading Update and Full-Year Results

The Company will publish a trading update for the year ended 31 March 2025 on 12 May 2025, followed by its audited full-year results in July 2025.

Disclosure of information required under Rule 4.9 of the Aquis Growth Market Access Rulebook

Keith Reginald Harris is, or has been in the last five years, a director of the following companies:

Dr Harris has no direct or indirect interest in the Company's issued share capital.

Dr Harris is a London-based investment banker and financier with a 25-year career as a senior corporate finance and takeover advisor. Since 1999, Dr. Harris has been the chairman of Keith Harris & Associates, a sports consulting firm. Dr Harris previously served as Chief Executive Officer of HSBC Investment Bank from 1994 to 1999.

Dr Harris received a BSc in business and economics from the University of Bradford and a PhD in Economics from the University of Surrey.

Dr Harris served as a director of Seymour Pierce Holdings Limited, a non-operating holding company, at the time administrators were appointed in February 2013. The appointment followed the sale of its sole wholly-owned asset, Seymour Pierce Limited, a company in which Dr Harris held no directorial position.

Except as set out above, there is no further information regarding Dr Harris that is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

Our board of directors believes that Dr Harris' financial knowledge and experience qualifies him to serve as a member of our board of directors.